Exosens
EXENS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €225 | €207 | €187 | €167 |
| % Growth | 8.3% | 10.9% | 12% | – |
| Cost of Goods Sold | €85 | €160 | €135 | €114 |
| Gross Profit | €139 | €47 | €179 | €138 |
| % Margin | 62% | 22.7% | 95.5% | 82.5% |
| R&D Expenses | €8 | €0 | €7 | €1 |
| G&A Expenses | €70 | €57 | €57 | €83 |
| SG&A Expenses | €71 | €59 | €28 | €46 |
| Sales & Mktg Exp. | €1 | €2 | €1 | €2 |
| Other Operating Expenses | €13 | -€40 | -€18 | €50 |
| Operating Expenses | €92 | €19 | €17 | €97 |
| Operating Income | €47 | €49 | €28 | €41 |
| % Margin | 20.8% | 23.7% | 14.8% | 24.6% |
| Other Income/Exp. Net | -€8 | -€12 | -€23 | -€38 |
| Pre-Tax Income | €38 | €37 | €5 | €11 |
| Tax Expense | €10 | €9 | €1 | €0 |
| Net Income | €28 | €28 | -€1 | €8 |
| % Margin | 12.4% | 13.4% | -0.3% | 5% |
| EPS | 0.55 | 0.65 | -0.045 | 0.085 |
| % Growth | -15.4% | 1,544.4% | -153.1% | – |
| EPS Diluted | 0.55 | 0.65 | -0.045 | 0.085 |
| Weighted Avg Shares Out | 51 | 43 | 51 | 30 |
| Weighted Avg Shares Out Dil | 51 | 43 | 51 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €7 | €8 | €19 | €25 |
| Depreciation & Amortization | €10 | €2 | €16 | €29 |
| EBITDA | €58 | €45 | €40 | €62 |
| % Margin | 25.6% | 21.9% | 21.6% | 37.2% |